After three years of intense restrictions, China has finally opened its borders. But one overarching question remains: Is China investable again?
According to the top research providers, the short answer is yes.
“Our outlook for China entering the new year is positive,” said Peng Wensheng, head of the research department at China International Capital Corp. “China’s macroeconomic policies have supported growth, and recent changes to Covid-19 and property sector policies will likely boost economic activity and corporate earnings in the coming quarters.”
CICC, along with UBS Securities, tied for No. 1 in Institutional Investor’s 13th annual All-China Research Team. This year’s ranking was based on the votes of 3,160 investments professionals across 975 institutions. Huatai Securities remained at No. 3, while JPMorgan rose three spots to No. 4. BofA Securities rounded out the top five.
To select the members of Institutional Investor’s thirteenth annual All-China Research Team, we solicited the opinions of some 3,160 investment professionals at 975 institutions.
Participants rated their top firms in each sector and then separately rated individual analysts, economists or strategists at those firms to create two distinct rankings for each sector. A numerical score was produced by weighting each vote by the respondent’s Chinese equity assets under management and the average rating awarded. Using those scores, ranks were determined. Firms and analysts were designated runners‐up when their scores came within 35 percent of the third-place scores.
In order to portray the difference in perspective between domestic and international investors, we divided respondents according to their location to produce two additional rankings: a mainland view and an international view.
The individuals surveyed are kept confidential to ensure continuing cooperation. Voters are subject to eligibility requirements, and winners must achieve a minimum vote count. All ballots are subject to review by our Research Operations Group.